Leys, Fabian
Fanciulli, Alessandra
Ndayisaba, Jean-Pierre
Granata, Roberta
Struhal, Walter
Wenning, Gregor K. http://orcid.org/0000-0001-9077-1666
Article History
Received: 5 February 2020
Accepted: 25 April 2020
First Online: 15 May 2020
Compliance with ethical standards
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest. Disclosure statement for the last 12 months: Dr. Leys reports no disclosures. Dr. Fanciulli reports royalties from Springer Nature, speaker fees and honoraria from the Ordensklinikum Linz, Austrian Parkinson Society, International Parkinson Disease and Movement Disorders Society, and Theravance, and research grants from the Stichting ParkinsonFond and the Österreichischer Austausch Dienst, outside of the submitted work. Dr. Phil Ndayisaba reports no disclosures. Dr. Granata reports no disclosures. Dr. Struhal reports royalties from Springer, Manz, and Oxford University Press, payment for lectures from AbbVie, Ever, Pfizer, Austrian Parkinson Society, and the Kardinal König Haus, and board membership of Lilly and Boehringer. Dr. Wenning reports research grants from the Austrian Science Foundation, Austrian National Bank Jubilee Fonds, Parkinson Fonds Austria, MSA Coalition, and the Tyrolean Science Foundation, consulting fees from Biohaven, Biogen, Lundbeck, Minoryx, Ono, Prana, and Teva, and speaker fees from Biohaven, Novartis, International Movement Disorder Society, and Scandinavian MDS.
: This study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Given the retrospective nature of this study, according to Austrian law, neither an approval by the local ethical committee nor a written informed consent was due. The local ethical committee was informed about the present study. Details that might disclose the identity of the subjects under study were removed. Data was archived and analyzed in a de-identified way.